0001209191-21-045049.txt : 20210702
0001209191-21-045049.hdr.sgml : 20210702
20210702170116
ACCESSION NUMBER: 0001209191-21-045049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210702
DATE AS OF CHANGE: 20210702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HALE DAVID F
CENTRAL INDEX KEY: 0001024004
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 211071139
MAIL ADDRESS:
STREET 1: 1042-B NORTH EL CAMINO REAL, SUITE 430
CITY: ENCINITAS
STATE: CA
ZIP: 92024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-30
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001024004
HALE DAVID F
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2021-06-30
4
S
0
3669
4.75
D
713152
I
By Hale BioPharma Ventures, LLC
Common Stock
18346
I
By Hale Trading Company
These shares were transferred to Oxford Finance LLC by Hale BioPharma Ventures, LLC in satisfaction of a pledge by Hale BioPharma Ventures, LLC which was previously disclosed by the Issuer.
/s/Chase C. Leavitt, Attorney-in-fact
2021-07-02